Abiomed announces q2 fy 2021 revenue of $210 million, up 27% over q1 fy 2021 and up 2% over q2 fy 2020 with 29.2% operating margin

Danvers, mass.--(business wire)--abiomed announces q2 fy 2021 revenue of $210 million, up 27% over q1 fy 2021 and up 2% over q2 fy 2020 with 29.2% operating margin.
ABMD Ratings Summary
ABMD Quant Ranking